DS-5670a

DS-5670a · Daiichi Sankyo Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DS-5670a, covering 2022-08-30 to 2022-08-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly Subjects [Phase 1, Phase 2]